| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |